292 related articles for article (PubMed ID: 8013414)
1. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
Lake BG; Evans JG; Cunninghame ME; Price RJ
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of nafenopin on hepatic peroxisome proliferation and replicative DNA synthesis in the rat and Syrian hamster.
Price RJ; Evans JG; Lake BG
Food Chem Toxicol; 1992 Nov; 30(11):937-44. PubMed ID: 1473786
[TBL] [Abstract][Full Text] [Related]
3. Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-beta1 gene expression in the rat, Syrian hamster and guinea pig.
Lake BG; Rumsby PC; Price RJ; Cunninghame ME
Mutat Res; 2000 Mar; 448(2):213-25. PubMed ID: 10725474
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883.
Eacho PI; Lanier TL; Brodhecker CA
Carcinogenesis; 1991 Sep; 12(9):1557-61. PubMed ID: 1893515
[TBL] [Abstract][Full Text] [Related]
5. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
Marsman DS; Cattley RC; Conway JG; Popp JA
Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
[TBL] [Abstract][Full Text] [Related]
6. Toxicity studies of WY-14,643 (CAS No. 50892-23-4) administered in feed to male Sprague-Dawley rats, B6C3F1 mice, and Syrian hamsters.
Cunningham ML
Toxic Rep Ser; 2007 Oct; (62):1-136. PubMed ID: 24743700
[TBL] [Abstract][Full Text] [Related]
7. Increased nuclear ploidy, not cell proliferation, is sustained in the peroxisome proliferator-treated rat liver.
Lalwani ND; Dethloff LA; Haskins JR; Robertson DG; de la Iglesia FA
Toxicol Pathol; 1997; 25(2):165-76. PubMed ID: 9125775
[TBL] [Abstract][Full Text] [Related]
8. Peroxisomal enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic liver foci of rats treated with a single dose of the peroxisome proliferator nafenopin.
Grasl-Kraupp B; Huber W; Timmermann-Trosiener I; Schulte-Hermann R
Carcinogenesis; 1993 Nov; 14(11):2435-7. PubMed ID: 8242878
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset.
Lake BG; Evans JG; Gray TJ; Körösi SA; North CJ
Toxicol Appl Pharmacol; 1989 Jun; 99(1):148-60. PubMed ID: 2499080
[TBL] [Abstract][Full Text] [Related]
10. Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid.
Marsman DS; Goldsworthy TL; Popp JA
Carcinogenesis; 1992 Jun; 13(6):1011-7. PubMed ID: 1600604
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats.
Biegel LB; Hurtt ME; Frame SR; O'Connor JC; Cook JC
Toxicol Sci; 2001 Mar; 60(1):44-55. PubMed ID: 11222872
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of peroxisomal enzymes, cytochrome P-452 and DNA synthesis in putative preneoplastic foci of rat liver treated with the peroxisome proliferator nafenopin.
Grasl-Kraupp B; Huber W; Just W; Gibson G; Schulte-Hermann R
Carcinogenesis; 1993 May; 14(5):1007-12. PubMed ID: 8099311
[TBL] [Abstract][Full Text] [Related]
13. Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell replication.
Wada N; Marsman DS; Popp JA
Fundam Appl Toxicol; 1992 Jan; 18(1):149-54. PubMed ID: 1601204
[TBL] [Abstract][Full Text] [Related]
14. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
[TBL] [Abstract][Full Text] [Related]
15. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis.
James NH; Roberts RA
Carcinogenesis; 1996 Aug; 17(8):1623-32. PubMed ID: 8761418
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats.
Hayashi F; Tamura H; Yamada J; Kasai H; Suga T
Carcinogenesis; 1994 Oct; 15(10):2215-9. PubMed ID: 7955056
[TBL] [Abstract][Full Text] [Related]
17. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.
Peters JM; Cattley RC; Gonzalez FJ
Carcinogenesis; 1997 Nov; 18(11):2029-33. PubMed ID: 9395198
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of di-(2-ethylhexyl)adipate on hepatic peroxisome proliferation and cell replication in the rat and mouse.
Lake BG; Price RJ; Cunninghame ME; Walters DG
Toxicology; 1997 Dec; 123(3):217-26. PubMed ID: 9355940
[TBL] [Abstract][Full Text] [Related]
19. Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643.
Marsman DS; Popp JA
Carcinogenesis; 1994 Jan; 15(1):111-7. PubMed ID: 7507413
[TBL] [Abstract][Full Text] [Related]
20. A comparison of liver protein changes in mice and hamsters treated with the peroxisome proliferator Wy-14,643.
Giometti CS; Tollaksen SL; Liang X; Cunningham ML
Electrophoresis; 1998 Oct; 19(14):2498-505. PubMed ID: 9820974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
